These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1985381)

  • 1. Prognosis of patients with ventricular tachycardia or fibrillation and a normal electrophysiologic study.
    Kim SG; Aboaf AP; Roth J; Ferrick K; Fisher JD
    Am Heart J; 1991 Jan; 121(1 Pt 1):77-80. PubMed ID: 1985381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification and management of patients with organic heart disease and nonsustained ventricular tachycardia: role of programmed stimulation, left ventricular ejection fraction, and the signal-averaged electrocardiogram.
    Turitto G; Fontaine JM; Ursell S; Caref EB; Bekheit S; el-Sherif N
    Am J Med; 1990 Jan; 88(1N):35N-41N. PubMed ID: 2368762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of programmed electrical stimulation and ambulatory electrocardiographic (Holter) monitoring in the management of ventricular tachycardia and ventricular fibrillation.
    Platia EV; Reid PR
    J Am Coll Cardiol; 1984 Sep; 4(3):493-500. PubMed ID: 6470328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in nonsustained ventricular tachycardia.
    Buxton AE; Marchlinski FE; Waxman HL; Flores BT; Cassidy DM; Josephson ME
    Am J Cardiol; 1984 May; 53(9):1275-9. PubMed ID: 6711427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy.
    Milner PG; Dimarco JP; Lerman BB
    Pacing Clin Electrophysiol; 1988 May; 11(5):562-8. PubMed ID: 2456534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of patients with sustained ventricular tachycardia and of survivors of cardiac arrest not inducible by programmed stimulation.
    Andresen D; Steinbeck G; Brüggemann T; Haberl R; Fink L; Schröder R
    Am J Cardiol; 1992 Nov; 70(15):1250-4. PubMed ID: 1442574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
    Burckhardt D; Robertson A; Hoffmann A; Pfisterer M
    J Clin Pharmacol; 1991 Nov; 31(11):1105-8. PubMed ID: 1753016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs.
    Graboys TB; Lown B; Podrid PJ; DeSilva R
    Am J Cardiol; 1982 Sep; 50(3):437-43. PubMed ID: 6180622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of survival in patients with ventricular tachyarrhythmias.
    Swerdlow CD; Winkle RA; Mason JW
    N Engl J Med; 1983 Jun; 308(24):1436-42. PubMed ID: 6855814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
    Buxton AE; Marchlinski FE; Flores BT; Miller JM; Doherty JU; Josephson ME
    Circulation; 1987 Jun; 75(6):1178-85. PubMed ID: 3568327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease.
    Lampert S; Lown B; Graboys TB; Podrid PJ; Blatt CM
    Am J Cardiol; 1988 Apr; 61(10):791-7. PubMed ID: 3354443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
    Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
    Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure.
    Brodsky MA; Allen BJ; Abate D; Henry WL
    Am Heart J; 1985 Oct; 110(4):794-9. PubMed ID: 4050651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation.
    Olson PJ; Woelfel A; Simpson RJ; Foster JR
    Am J Cardiol; 1993 Apr; 71(10):823-6. PubMed ID: 8456761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death.
    Watson RM; Schwartz JL; Maron BJ; Tucker E; Rosing DR; Josephson ME
    J Am Coll Cardiol; 1987 Oct; 10(4):761-74. PubMed ID: 3655144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
    Herre JM; Sauve MJ; Malone P; Griffin JC; Helmy I; Langberg JJ; Goldberg H; Scheinman MM
    J Am Coll Cardiol; 1989 Feb; 13(2):442-9. PubMed ID: 2913120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
    Myers M; Peter T; Weiss D; Nalos PC; Gang ES; Oseran DS; Mandel WJ
    Am Heart J; 1990 Jan; 119(1):8-14. PubMed ID: 2296879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups.
    Poole JE; Mathisen TL; Kudenchuk PJ; McAnulty JH; Swerdlow CD; Bardy GH; Greene HL
    J Am Coll Cardiol; 1990 Sep; 16(3):657-65. PubMed ID: 2387939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias.
    Hohnloser SH; Raeder EA; Podrid PJ; Graboys TB; Lown B
    Am Heart J; 1987 Jul; 114(1 Pt 1):1-7. PubMed ID: 3604854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.